In Focus
Late and Long‐Term Effects of Breast Cancer Treatment and Surveillance Management for the General Practitioner

https://doi.org/10.1111/1552-6909.12300Get rights and content

ABSTRACT

Objective

To examine the most common long‐term and late effects of breast cancer treatment, the American Society of Clinical Oncology guidelines for surveillance, and recommendations for the primary care provider's role in delivering breast cancer survivorship care.

Data Sources

A comprehensive literature review was conducted using CINAHL, PubMed, Google Scholar, and hand searches using the search terms breast cancer, survivor, and long‐term or late effects.

Study Selection

Articles published in English from 2002 to 2012 that addressed the long‐term or late effects of adults with breast cancer were included.

Data Extraction

Findings are discussed categorically, including the most common late and long‐term psychosocial effects from relevant studies.

Data Synthesis

Topics relevant to survivors included challenges to psychosocial, emotional, and cognitive well‐being; satisfaction with life; sexuality; body image; anxiety; fear of recurrence and post‐traumatic stress disorder; depression; cognitive dysfunction challenges to physical well‐being; adverse cardiovascular events; fatigue; lymphedema; musculoskeletal symptoms; accelerated bone loss and fractures; pain; skin changes due to radiation; disease recurrence; and new breast cancers.

Conclusions

With earlier detection methods and improvements in treatment options making breast cancer a highly survivable disease, there are more survivors of breast cancer than ever. The clinicians’ role in survivorship care is more important than ever to manage the potential long‐term and late effects of treatment, physical and emotional well‐being, and recurrent disease surveillance. However, the clinician's role in cancer follow‐up care is often poorly defined leading to a lack of awareness about the needs of survivors of breast cancer, suboptimal communication between providers and survivors, and an overall deficiency in quality care.

Section snippets

Methods

A comprehensive literature review was conducted using CINAHL, PubMed, Google Scholar, and hand searches of articles published in English between 2002 and 2012. A CINAHL search was performed using the search terms breast cancer and survivor and long‐term (resulting in 202 articles) and breast cancer and survivor and late effects (resulting in 31 articles). A PubMed search was conducted using the search terms breast cancer and survivor and long‐term treatment effects (resulting in 137 articles)

Psychosocial, Emotional, and Cognitive Effects

Long‐term (at least 5 years from diagnosis) psychosocial effects of cancer treatment may include components related to behavioral, psychological, or social functioning (Jacobsen, 2009). Table 1 lists the most common psychosocial effects related to breast cancer and treatment: anxiety, depression, posttraumatic stress disorder (PTSD), decreased satisfaction with life, fear of recurrence, poor body image, and sexual dysfunction. Survivors felt they were inadequately informed about the potential

Disease Recurrence and New Breast Cancers

If breast cancer recurs, it will most likely occur within 3 to 5 years of the original diagnosis; however, 25% of metastatic cases occur beyond that time (Hollowell et al., 2010). The most common sites of metastasis are the locoregional recurrence, lungs, liver, and bones (NCI, 2013). Additionally, there is a 1% per year risk of a second primary breast cancer in the contralateral breast (NCI, 2013). Women with contralateral breast cancer are also at higher risk of developing distant recurrence.

Providers’ Barriers to Care of Survivors of Cancer

There are five vital components for care of survivors of cancer: preventing late effects, second malignancies, and recurrent cancers; surveillance for recurrence, metastasis, or new cancers; monitoring for late medical and psychosocial effects; intervention for adverse effects of diagnosis and treatment; and coordination between specialists and primary care providers to successfully meet the needs of survivors (Hewitt, Greenville, & Stovall, 2005; NCCN, 2013). Several barriers must be addressed

Recommendations and Conclusion

A large part of the care of survivors of breast cancer is defining who will be responsible for screening for disease recurrence and identifying and managing the late and long‐term effects of treatment. Current 2013 ASCO guidelines state patients with early‐stage breast cancer (tumor less than 5 centimeters and less than four positive nodes) may transfer follow‐up care exclusively to their primary care provider one year after diagnosis. However, primary care providers must be provided with the

Megan Kenyon, MSN, ANP-BC, is a nurse practitioner in the Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC.

REFERENCES (99)

  • J.R. Freeman et al.

    Assessing cognitive dysfunction in breast cancer: What are the tools?

    Clinical Breast Cancer

    (2002)
  • B.V. Jensen et al.

    Functional monitoring of anthracycline cardiotoxicity: A prospective, blinded, long‐term observational study of outcome in 120 patients

    Annals of Oncology

    (2002)
  • S.H. Kim et al.

    Fatigue and depression in disease‐free breast cancer survivors: Prevalence, correlates, and association with quality of life

    Journal of Pain & Symptom Management

    (2008)
  • B.A. Mincey et al.

    Risk of cancer treatment‐associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors

    Clinical Breast Cancer

    (2006)
  • F. Mols et al.

    Quality of life among long‐term breast cancer survivors: A systematic review

    European Journal of Cancer

    (2005)
  • R.M. Morrell et al.

    Breast cancer‐related lymphedema

    Mayo Clinic Proceedings

    (2005)
  • K. Oktay et al.

    GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation

    Reproductive Biomedicine

    (2010)
  • C. Reyes‐Gibby et al.

    Chemotherapy‐induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel

    Journal of Pain

    (2009)
  • H.S. Rugo

    Strategies for the prevention of treatment‐related bone loss in women receiving adjuvant hormonal therapy

    Clinical Breast Cancer

    (2007)
  • H. Sackey et al.

    Ductal carcinoma in situ of the breast. Long‐term follow‐up of health‐related quality of life, emotional reactions and body image

    European Journal of Surgical Oncology

    (2010)
  • C. Shah et al.

    Breast cancer‐related arm lymphedema: Incidence rates, diagnostic techniques, optimal management, and risk reduction strategies

    International Journal of Radiation Oncology

    (2011)
  • A. Taghian et al.

    Long‐term risk of sarcoma following radiation treatment for breast cancer

    International Journal of Radiation Oncology Biology Physics

    (1991)
  • Cancer care for the whole patient: Meeting psychosocial health needs

  • T.A. Ahles et al.

    Neuropsychologic impact of standard‐dose systemic chemotherapy in long‐term survivors of breast cancer and lymphoma

    Journal of Clinical Oncology

    (2002)
  • R.L. Ahmed et al.

    Risk factors for lymphedema in breast cancer survivors, the Iowa women's health study

    Breast Cancer Research and Treatment

    (2011)
  • American Cancer Society

    Breast cancer facts and figures 2011–2012

    (2011)
  • American Cancer Society

    Breast cancer

    (2012)
  • American Psychological Association

    Post-traumatic stress disorder

    (2013)
  • N.E. Avis et al.

    Psychosocial problems among younger women with breast cancer

    Psycho‐Oncology

    (2004)
  • F.L. Balci et al.

    Breast cancer‐related lymphedema in elderly patients

    Topics in Geriatric Rehabilitation

    (2012)
  • C.M. Bender et al.

    What do perceived cognitive problems reflect?

    Journal of Supportive Oncology

    (2008)
  • A.M. Berger et al.

    Cancer‐related fatigue

    Journal of the National Comprehensive Cancer Network

    (2010)
  • A.M. Berger et al.

    Cancer‐related fatigue: Implications for breast cancer survivors

    Cancer

    (2012)
  • L.J. Blakely et al.

    Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence

    Cancer

    (2004)
  • A.M. Brewster et al.

    Residual risk of breast cancer recurrence 5 years after adjuvant therapy

    Journal of the National Cancer Institute

    (2008)
  • A guide to oncology symptom management

  • C. Burgess et al.

    Depression and anxiety in women with early breast cancer: Five year observational cohort study

    BMJ

    (2005)
  • H.J. Burstein et al.

    American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor‐positive breast cancer

    Journal of Clinical Oncology

    (2010)
  • M.F. Chen et al.

    Predictive factors of radiation‐induced skin toxicity in breast cancer patients

    BioMed Central

    (2010)
  • K. Clough‐Gorr et al.

    Older breast cancer survivors: Factors associated with self‐reported symptoms of persistent lymphedema over 7 years of follow‐up

    Breast Journal

    (2010)
  • M. Crump et al.

    Risk of acute leukemia following epirubicin‐based adjuvant chemotherapy: A report from the National Cancer Institute of Canada Clinical Trials Group

    Journal of Clinical Oncology

    (2003)
  • K.H. Dow et al.

    Fertility options in young breast cancer survivors: A review of the literature

    Oncology Nursing Forum

    (2004)
  • J.J. Doyle et al.

    Chemotherapy and cardiotoxicity in older breast cancer patients: A population‐based study

    Journal of Clinical Oncology

    (2005)
  • C.C. Earle

    Failing to plan is planning to fail: Improving the quality of care with survivorship care plans

    Journal of Clinical Oncology

    (2006)
  • R. Enck

    Postsurgical chronic pain

    American Journal of Hospice and Palliative Medicine

    (2010)
  • J. Engel et al.

    Quality of life following breast‐conserving therapy or mastectomy: Results of a 5‐year prospective study

    The Breast Journal

    (2004)
  • R.J. Ferguson et al.

    Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy

    Journal of Clinical Oncology

    (2007)
  • P. Ganz et al.

    Quality of life in long‐term, disease‐free survivors of breast cancer: A follow‐up study

    Journal of the National Cancer Institute

    (2002)
  • R. Gartner et al.

    Prevalence of and factors associated with persistent pain following breast cancer surgery

    Journal of the American Medical Association

    (2009)
  • Cited by (75)

    • Psychometric assessment of the Concerns about Late Effects in Oncology Questionnaire (CLEO) among female breast cancer survivors

      2022, Patient Education and Counseling
      Citation Excerpt :

      Late effects are side effects of cancer treatment that only emerge months to years after active treatment completion and are unpredictable in onset, duration, and severity [3–5]. Cancer treatments such as chemotherapy, radiotherapy and surgery have been implicated in the development of late effects [6–8]. Late effects can be functionally debilitating.

    View all citing articles on Scopus

    Megan Kenyon, MSN, ANP-BC, is a nurse practitioner in the Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC.

    Deborah K. Mayer, PhD, RN, AOCN, FAAN, is an associate professor in the School of Nursing, University of North Carolina-Chapel Hill, Chapel Hill, NC.

    Anna Kate Owens, RN, MSN, FNP-BC, is a nurse practitioner in the Breast Cancer Program, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

    View full text